Researchers from Memorial Sloan Kettering Cancer Center and from MIT are reporting the development of a new combination therapy that completely eliminates colon cancer, at least in laboratory mice. The technique is a type of radioimmunotherapy, which delivers radioactive particles directly to tumors on the backs of targeting antibodies that seek out those tumors. In their […]
Month: November 2017
Ocular Therapeutix™ Reports Third Quarter 2017 Financial Results and Provides Corporate Update
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the third quarter ended September 30, 2017, and provided a corporate update. “In addition to refining our manufacturing process for DEXTENZA™, we are also working diligently on a continuous improvement plan that will bring our manu
Nanoporous Needles May Significantly Boost Effectiveness of Acupuncture
Acupuncture still has a way to go to prove itself useful in many clinical applications, but its effectiveness may be significantly boosted by improving the needles that are used. A study in journal Nature Scientific Reports by researchers at DGIST (Daegu Gyeongbuk Institute of Science and Technology in South Korea) introduces acupuncture needles that have minuscule holes […]
Alimera posts $5.3 million quarterly loss
Alimera Sciences reported a GAAP net loss of $5.3 million in the third quarter of 2017 compared with a loss of $9.2 million in 2016’s third quarter.
Quarterly basic and diluted net loss was $0.08 per share compared with a basic and diluted net loss of $0.16 per share last year, according to a company press release.
Consolidated net revenue rose by $1.5 million to $9.8 million in the quarter compared with net revenue of $8.3 million in the third quarter of 2016.
Operating expenses decreased to $12.6 million in the quarter compared with $15.1 million in 2016’s third quarter, while the
Claris Reflex Brings Monitored Rehab Following Total Knee Replacement to The Home
Claris Healthcare, a company with offices in Vancouver, Canada and Ferndale, Washington, is releasing its novel Claris Reflex knee rehab monitoring system. The product consists of a sensor attached to the leg, above and below the knee, that constantly measures the flexion and extension of a knee that underwent a surgical procedure, and a software […]
Medtronic’s Compact Intellis Implantable Neurostimulation System Cleared in Europe
Medtronic won European regulatory approval for its Intellis system, which can be used for either spinal cord or peripheral nerve neurostimulation to help relieve chronic pain. This is currently the smallest implantable spinal cord stimulator on the market, which was released in the U.S. only a couple of months ago. The Intellis implant delivers both […]
Exponential Medicine by Singularity University Live Streaming This Week
For those excited for, but unable to attend, Exponential Medicine 2017 conference this week organized by Singularity University, can check out the event’s live stream to tune in for a wide range of speakers, presentations, and announcements. This year’s event speakers include some perennial favorites and a couple new faces: Daniel Kraft, MD Faculty Chair for […]
microMend, a Novel and Time-Saving Wound Closure Device
Sutures and staples are the usual options for closing wounds postoperatively, but they can be painful and require surgical skills. The microMend Skin Closure Device, produced by Seattle-based KitoTech Medical, provides a potentially better alternative. The design of the microMend is conceptually similar to a bandage, like Steri-Strip. The device is made of a thin […]
Kala Pharmaceuticals submits NDA for Inveltys
Kala Pharmaceuticals has submitted a new drug application to the FDA for Inveltys, its inflammation and pain treatment candidate for those who have undergone ocular surgery, according to a company press release.
Inveltys (KPI-121 1%) is a twice-a-day topical ocular corticosteroid that utilizes the company’s proprietary mucus penetrating particle (MPP) technology, selectively sized nanoparticles with coatings that enhance drug penetration and distribution in ocular tissues, the release said.
Two phase 3 clinical trials, in which Inveltys achieved statistical significance over placebo in
ACP: Physicians must promote patient safety
Jack Ende
ACP recently published a new position paper asserting that improvements to patient safety are gravely needed in the outpatient setting while offering recommendations to address the issue.
“In recent years, much attention has been focused on improving patient safety in hospitals,” Jack Ende, MD, MACP, president of ACP, said in a press release. “We now must extend that focus to include the ambulatory setting. Medical errors that happen outside of the hospital are just as important to prevent.”
The paper, “Patient Safety in the Office-Based Practice Setting,”
Tear Film Innovations Completes $9 Million Series A Funding
SAN DIEGO–(BUSINESS WIRE)–Tear Film Innovations completes $9 million Series A funding round with Visionary Ventures Fund, L.P.
Versant, NEA Back Oyster Point Pharma
SAN FRANCISCO–(BUSINESS WIRE)–Oyster Point raises $22M Series A from NEA, Versant
Kala Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Business Update
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals reported financial results for the third quarter and nine months ended September 30, 2017 and provided a business update.
Aerie Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and…
NovaBay Pharmaceuticals to Hold Third Quarter 2017 Conference Call on November 14
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, announces that it will report third quarter 2017 financial results after market close on Tuesday, November 14. Management will hold an investment community conference call that day to discuss financial results and provide a Company update. DATE: Tuesday, Novem
No changes seen in surgical time, corneal edema with hydrogel sealant
Eyes with hydrogel ocular sealant used to secure clear corneal incisions during cataract surgery experienced no statistical differences in wound leaks, total surgical time or corneal edema compared with non-sealant eyes.Researchers retrospectively revi…
LumiThera secures $5.5 million in Series B financing
LumiThera has closed $5.5 million in Series B financing to support development of its LT-300 device for treating dry age-related macular degeneration, according to a company press release.
The lead investor was WaterStone Capital, with RPR Venture as a co-investor.
Proceeds from the financing will be used to continue the company’s work obtaining regulatory clearances in Europe and additional countries outside of the United States.
“We are pleased with the investor interest in the company and have oversubscribed the Series B round,” Clark Tedford, PhD, president and CEO of
What is a heliotrope rash?
A heliotrope rash may appear as a purple rash on or around the eyelids. Learn more about the causes and risk factors of this rash.
VIDEO: OCTANe’s annual Medical Technology Innovation Forum grows
NEWPORT BEACH Calif. — Bill Carpou, CEO of OCTANe, discusses the annual Medical Technology Innovation Forum, including how the meeting has grown and how the quality of companies participating is improving.
trans-Tango, a Brain Network Mapping Technique to Help Understand Neuro Diseases
Researchers at Brown University have developed a practical new way of imaging the activity between individual neurons in the brain, providing scientists with a powerful tool to study neural diseases, their causes, and potential treatments. The technology has been trialed in fruit flies and has already resulted in previously unmapped neural circuits related to eating […]